Search Results

Baxter Reports First-Quarter 2023 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the first quarter of 2023.

Baxter Launches Zosyn Premix In US

Baxter International Inc. (NYSE:BAX), a global leader in sterile medication production and delivery, today announced the U.S. launch of ZOSYN (piperacillin and tazobactam) Injection. Zosyn premix is indicated for the treatment of multiple infections caused by susceptible bacteria and is available in Baxter’s proprietary single-dose Galaxy containers.

Turn Insights Into Action With Connected Medical Devices

As we strive to build digital health solutions that help streamline hospital operations and personalize patient care, we are collaborating with Amazon Web Services (AWS) to deliver actionable insights that can help clinicians make informed decisions.

Baxter Reports Fourth-Quarter and Full-Year 2022 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the fourth quarter and full year ended Dec. 31, 2022, and provided its financial guidance for full-year and first-quarter 2023. 

Baxter Announces Strategic Actions to Enhance Operational Effectiveness, Accelerate Innovation for Patients and Drive Value for Shareholders

Baxter International Inc. (NYSE:BAX), a leading global medtech company, today announced a comprehensive strategic roadmap to meaningfully enhance its operational effectiveness, drive toward improved long-term performance, accelerate innovation and create additional value for all stakeholders.

Baxter Highlights New Home Dialysis and HDx Therapy Data in 14 Clinical Presentations at Kidney Week 2022

Baxter International Inc. (NYSE:BAX), a global innovator in kidney care, advanced scientific exchange with 14 new data presentations about the role innovation plays in increasing access to and quality of home dialysis and expanded hemodialysis (HDx) care at Kidney Week 2022, Nov. 3-6, Orlando, Florida. Key data highlighted include:

Activating Our Passion to Increase Kidney Care Access

We spoke with Peter Rutherford, MB BS, PhD, FRCP, vice president of Worldwide Medical Affairs for our Renal Care business, about his experience as a practicing nephrologist and his quest to improve global access to kidney care and patient outcomes.   

Baxter Reports Third-Quarter 2022 Results

Baxter International Inc. (NYSE:BAX), a global medtech leader, today reported results for the third quarter of 2022.

Baxter Broadens Efforts to Increase Awareness, Education and Support of Kidney Health in Black Communities

Baxter International Inc. (NYSE:BAX), a global medtech leader, announces the national expansion of its partnership with international not-for-profit organization The Links, Incorporated (The Links) to continue bringing awareness and resources for the disproportionate challenges affecting Black Americans related to kidney health.

Semiconductor Chip Shortage is Impacting Patient Care Globally

Baxter International Inc. (NYSE:BAX), a global medtech leader, and its suppliers have been impacted by shortages of electromechanical components, including semiconductor chips, used in many of its products. Several of the company's critical products require multiple chips per device, including infusion pumps, patient monitoring systems and continuous renal replacement therapy systems.